Ms Beld is currently at the Department of Pharmacotherapy and Pharmaceutical care, Pharmacy and Pharmaceutical Science, University of Groningen, Groningen, the Netherlands.
Review of psychotropic medication in Tasmanian residential aged care facilities
Article first published online: 8 FEB 2010
© 2010 The Authors. Journal compilation © 2010 ACOTA
Australasian Journal on Ageing
Volume 29, Issue 2, pages 72–76, June 2010
How to Cite
Westbury, J., Beld, K., Jackson, S. and Peterson, G. (2010), Review of psychotropic medication in Tasmanian residential aged care facilities. Australasian Journal on Ageing, 29: 72–76. doi: 10.1111/j.1741-6612.2010.00409.x
- Issue published online: 8 JUN 2010
- Article first published online: 8 FEB 2010
- medication review;
- residential aged care facilities
Aim: To examine psychotropic medication review practices in residential aged care facilities.
Methods: Psychotropic medicine use data were collected from residents from 40 residential aged care facilities throughout Tasmania. As an indication of review practices, the measure was repeated at 33 of the original facilities a year later.
Results: A total of 2389 residents' medication records were examined in 2006. Regular doses of antipsychotics and benzodiazepines were taken by 42% and 21% of residents, respectively. Medication data were available for 1307 of the residents in 2007. Over 60% were taking the same antipsychotic or benzodiazepine agent, at the same dose in 2007, as they were in 2006. Dosage reduction or cessation occurred in less than a quarter of the residents.
Conclusion: The utilisation of psychotropic medication is high in Tasmanian residential aged care facilities. Attempts to reduce psychotropic doses happen infrequently. Further research is required to establish the barriers to appropriate psychotropic medication review in this setting.